General description
The major cell-permeable diterpene isolated from the Indian plant Coleus forskohlii. At low doses, it acts as a positive inotropic agent. At higher doses, it serves as a hypotensive and vasodilatory agent due to its actions as a smooth muscle relaxant. No major side effects are observed at effective doses. Forskolins pharmacological activities are due to its activation of adenylate cyclase (EC50 = 4 µM), resulting in increased cAMP levels. The exact mechanism of forskolins positive inotropic effect is unknown but may be related to a cAMP-dependent increase in Na+ permeability that results in indirect augmentation of Ca2+ release. Inhibits MAP kinase in rat renal mesangial cells (IC50 = 25 µM). Also acts as a Hh pathway antagonist. Shown to inhibit apoptosis in cerebellar granule cells and to induce apoptosis in resting human B lymphocytes.
The major cell-permeable diterpene isolated from the Indian plant Coleus forskohlii. At low doses, it acts as a positive inotropic agent. At higher doses, it serves as a hypotensive and vasodilatory agent due to its actions as a smooth muscle relaxant. No major side effects are observed at effective doses. Forskolins pharmacological activities are due to its activation of adenylate cyclase (EC50 = 4 µM), resulting in increased cAMP levels. The exact mechanism of forskolins positive inotropic effect is unknown but may be related to a cAMP-dependent increase in Na+ permeability that results in indirect augmentation of Ca2+ release. Inhibits MAP kinase in rat renal mesangial cells (IC50 = 25 µM). Also acts as a Hh pathway antagonist. Shown to inhibit apoptosis in cerebellar granule cells and to induce apoptosis in resting human B lymphocytes. The solid form of this compound (Cat. No. 344270) is also available.
The major cell-permeable diterpene isolated from the Indian plant Coleus forskohlii.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
D′Orazio, J.A., et al. 2006. Nature443, 340.Noveen, A., et al. 1996. Biochem. Biophys. Res. Commun.219, 180.Galli, C., et al. 1995. J. Neurosci.15, 1172.Li, X., et al. 1995. Am. J. Physiol.269, C986.Lomo, J., et al. 1995. J. Immunol.154, 1634.Uneyama, H., et al. 1993. J. Biol. Chem.268, 168.Laurenza, A., et al. 1989. Trends Pharmacol. Sci.10, 442.Adashi, E.Y., and Resnick, C.E. 1986. J. Cell. Biochem.31, 217.Seamon, K.B., and Daly, J.W. 1986. Adv. Cyclic Nucleotide Protein Phosphorylation Res.20, 1.Huang, R., et al. 1982. Cyclic Nucleotide Res.8, 385.Metzger, H., and Lindner, E. 1981. IRCS Med. Sci. Biochem. Cardiovasc. System Pharmacol.9, 99.
Packaging
5 mg in Glass bottle
Packaged under inert gas
Physical form
A 50 mM (5 mg/244 µl) solution of Forskolin, Coleus forskohlii (Cat. No. 344270) in DMSO.
Reconstitution
Following initial thaw, aliquot and freeze (-20°C).
Warning
Toxicity: Irritant (B)
This product has met the following criteria to qualify for the following awards: